Literature DB >> 16230871

Hyponatremia and heart failure--pathophysiology and implications.

Domenic A Sica1.   

Abstract

Fluid and electrolyte disturbances are a common feature of heart failure. Among the electrolyte disturbances that occur in heart failure, disorders of potassium and magnesium have traditionally received the most attention. Abnormalities involving either of these actions serve as risk factors for sudden cardiac death/arrhythmias. More recently, a growing appreciation has emerged for the importance of hyponatremia in the heart failure patient. Hyponatremia is multifactorial in origin, and its presence correlates with disease severity and outcome. There are few effective therapies for hyponatremia, and those that are available are not viewed as offering specific survival benefits per se. The recent availability of vasopressin receptor antagonists, however, offers a different approach to the management of this complex electrolyte disturbance, but one that is still evolving as to the scope of its clinical benefits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230871     DOI: 10.1111/j.1527-5299.2005.04180.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  16 in total

1.  Hyponatremia and mortality among very elderly residents in a geriatric health service facility.

Authors:  Tamayo Naka; Kentaro Kohagura; Masako Kochi; Yusuke Ohya
Journal:  Clin Exp Nephrol       Date:  2018-06-27       Impact factor: 2.801

Review 2.  Significance of hyponatremia in heart failure.

Authors:  Luca Bettari; Mona Fiuzat; Gary M Felker; Christopher M O'Connor
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  Hyponatremia in patients with heart failure.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Cardiol       Date:  2013-09-26

Review 4.  Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Authors:  Melissa A Wasilewski; Valerie D Myers; Fabio A Recchia; Arthur M Feldman; Douglas G Tilley
Journal:  Cell Signal       Date:  2015-07-30       Impact factor: 4.315

Review 5.  Hyponatremia in heart failure.

Authors:  Dimitrios Farmakis; Gerasimos Filippatos; John Parissis; Dimitrios Th Kremastinos; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

6.  Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients.

Authors:  Savina Nodari; Geoffrey T Jao; Jun R Chiong
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-05-10

Review 7.  Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.

Authors:  Caterina Urso; Salvatore Brucculeri; Gregorio Caimi
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 8.  Well tolerated spironolactone-related hyponatremia.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-04       Impact factor: 3.738

Review 9.  Review of Tolvaptan's Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions.

Authors:  Purav R Bhatt; Elizabeth B McNeely; Tess E Lin; Kirkwood F Adams; J Herbert Patterson
Journal:  J Clin Med       Date:  2014-11-12       Impact factor: 4.241

10.  Short term efficacy and safety of low dose tolvaptan in patients with acute decompensated heart failure with hyponatremia: a prospective observational pilot study from a single center in South India.

Authors:  Soumya Patra; Basant Kumar; Kaushal K Harlalka; Apoorva Jain; H M Bhanuprakash; K S Sadananda; Harsha Basappa; K Santhosh; K S Rajith; K S Bharathi; C N Manjunath
Journal:  Heart Views       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.